Orsula V. Knowlton - Jul 14, 2021 Form 4 Insider Report for Tabula Rasa HealthCare, Inc. (TRHC)

Role: President, Director
Signature: /s/ Brian W. Adams, by Power of Attorney
Stock symbol: TRHC
Transactions as of: Jul 14, 2021
Transactions value $: -$468,200
Form type: 4
Date filed: 7/16/2021, 07:07 PM
Previous filing: Jun 17, 2021
Next filing: Nov 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TRHC	Common Stock	Sale	-$468K	-10K	-1.43%	$46.82	691K	Jul 14, 2021	Direct	F1, F2
holding	TRHC	Common Stock						825K	Jul 14, 2021	Held by spouse.
holding	TRHC	Common Stock						20K	Jul 14, 2021	Held by trust for children.
holding	TRHC	Common Stock						20K	Jul 14, 2021	Held by trust for children.

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.
F2	The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.48 to $47.30, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.

Content

The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2021.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $46.48 to $47.30, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.